Skip to Content

Remsima 100 mg powder for concentrate for solution for infusion

Licence status
Authorised: 10/09/2013
Active substances
Infliximab
Dosage Form
Powder for concentrate for solution for infusion
Licence number
EU/1/13/853/001
Licence holder
Celltrion Healthcare Hungary Kft.

Licence information

ATC code
L04AB02 infliximab
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
10/09/2013